José Van der Heyden

4.9k citations

61 papers · 4.0k indexed · 1 hit paper · h-index 32

Immunology top 1%
Molecular Biology top 10%
Oncology top 5%
Physiology top 5%
Radiology, Nuclear Medicine and Imaging top 2%

Co-authors: Jan Tavernier René Devos Walter Fiers Geert Plaetinck Lucie Fransen Sigrid Cornelis T Tuypens Yves Guisez
Topics: Monoclonal and Polyclonal Antibodies Research (19 papers)Cytokine Signaling Pathways and Interactions (13 papers)Viral Infectious Diseases and Gene Expression in Insects (10 papers)
Cited by: Immunology Endocrine and Autonomic Systems Immunology and Allergy
Journals: Nature Cell Proceedings of the National Academy of Sciences
Partner nations: Belgium France United States

In The Last Decade

José Van der Heyden

60 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF

1991 511 citations Jan Tavernier, René Devos et al. profile →

Peers

Countries citing papers authored by José Van der Heyden

Since Specialization

Citations

This map shows the geographic impact of José Van der Heyden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Van der Heyden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Van der Heyden more than expected).

Fields of papers citing papers by José Van der Heyden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Van der Heyden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Van der Heyden. The network helps show where José Van der Heyden may publish in the future.

Co-authorship network of co-authors of José Van der Heyden

This figure shows the co-authorship network connecting the top 25 collaborators of José Van der Heyden. A scholar is included among the top collaborators of José Van der Heyden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Van der Heyden. José Van der Heyden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma 2017 ·Molecular Cancer Therapeutics ·Ahmet Krasniqi,Matthias D’Huyvetter,Catarina Xavier,Kevin Van der Jeught,Serge Muyldermans,José Van der Heyden,Tony Lahoutte,Jan Tavernier,Nick Devoogdt	55
2	Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments 2017 ·Cancer Research ·Anje Cauwels,Sandra Van Lint,Franciane Paul,Geneviève Garcin,Stefaan De Koker,Alexander Van Parys,(unknown),Sarah Gerlo,José Van der Heyden,Yann Bordat,Dominiek Catteeuw,Elke Rogge,Annick Verhee,Bart Vandekerckhove,(unknown),Gilles Uzé,Jan Tavernier	75
3	TYK2-induced phosphorylation of Y640 suppresses STAT3 transcriptional activity 2017 ·Scientific Reports ·(unknown),Joris Wauman,Laura Icardi,José Van der Heyden,Lode De Cauwer,Frank Peelman,Karolien De Bosscher,Jan Tavernier	16
4	High efficiency cell-specific targeting of cytokine activity 2014 ·Nature Communications ·Geneviève Garcin,Franciane Paul,(unknown),Yann Bordat,José Van der Heyden,Stephan Wilmes,Guillaume Cartron,Florence Apparailly,Stefaan De Koker,Jacob Piehler,Jan Tavernier,Gilles Uzé	65
5	MAPPIT as a High-Throughput Screening Assay for Modulators of Protein–Protein Interactions in HIV and HCV 2011 ·Methods in molecular biology ·(unknown),(unknown),(unknown),Dirk Jochmans,R. Clayton,Jan Martin Berke,Sam Lievens,José Van der Heyden,Jan Tavernier	6
6	MAPPIT (MAmmalian Protein–Protein Interaction Trap) as a tool to study HIV reverse transcriptase dimerization in intact human cells 2008 ·Journal of Virological Methods ·Els Pattyn,Delphine Lavens,José Van der Heyden,Annick Verhee,Sam Lievens,Irma Lemmens,Sabine Hallenberger,Dirk Jochmans,Jan Tavernier	15
7	Inquiring into the Differential Action of Interferons (IFNs): an IFN-α2 Mutant with Enhanced Affinity to IFNAR1 Is Functionally Similar to IFN-β 2006 ·Molecular and Cellular Biology ·Diego Adhemar Jaitin,Laila C. Roisman,(unknown),Martynas Gavutis,Jacob Piehler,José Van der Heyden,Gilles Uzé,Gideon Schreiber	193
8	Functional Cartography of the Ectodomain of the Type I Interferon Receptor Subunit ifnar1 2005 ·Journal of Molecular Biology ·Peter Lamken,Martynas Gavutis,(unknown),José Van der Heyden,Gilles Uzé,Jacob Piehler	44
9	Functional Analysis of Leptin Receptor Activation Using a Janus Kinase/Signal Transducer and Activator of Transcription Complementation Assay 2003 ·Molecular Endocrinology ·Lennart Zabeau,(unknown),José Van der Heyden,Hannes Iserentant,Joël Vandekerckhove,Jan Tavernier	86
10	Enhanced soluble interleukin‐5 receptor alpha expression in nasal polyposis 2003 ·Allergy ·Philippe Gevaert,Claus Bachert,Gabriële Holtappels,Claudina Pérez-Novo,José Van der Heyden,Lucie Fransen,Stany Depraetere,H. Walter,Paul Van Cauwenberge,Jan Tavernier	81
11	Neutralizing monoclonal antibodies can potentiate IL-5 signaling 2001 ·European Journal of Immunology ·Lennart Zabeau,José Van der Heyden,D. Broekaert,Annick Verhee,Joël Vandekerckhove,(unknown),Irwin Chaiken,Peter C. Heinrich,Iris Behrmann,Jan Tavernier	14
12	Design and application of a cytokine-receptor-based interaction trap 2001 ·Nature Cell Biology ·Sven Eyckerman,Annick Verhee,José Van der Heyden,Irma Lemmens,Xaveer Van Ostade,Joël Vandekerckhove,Jan Tavernier	160
13	Ligand-independent Dimerization of the Extracellular Domain of the Leptin Receptor and Determination of the Stoichiometry of Leptin Binding 1997 ·Journal of Biological Chemistry ·René Devos,Yves Guisez,José Van der Heyden,David W. White,Michaël Kalai,Michael Fountoulakis,Geert Plaetinck	136
14	Structure/Function Analysis of Human Interleukin 5 and its Receptor 1995 ·Birkhäuser Basel eBooks ·Jan Tavernier,Sigrid Cornelis,(unknown),Yves Guisez,Geert Plaetinck,José Van der Heyden	4
15	Covalent modification of the interleukin‐5 receptor by isothiazolones leads to inhibition of the binding of interleukin‐5 1994 ·European Journal of Biochemistry ·René Devos,Yves Guisez,Geert Plaetinck,Sigrid Cornelis,Jan Tavernier,José Van der Heyden,Louise H. Foley,Julie E. Scheffler	39
16	Expression, purification and crystallization of fully active, glycosylated human interleukin‐5 1993 ·FEBS Letters ·(unknown),Christian Oefner,(unknown),Ernst‐Jürgen Schlaeger,M. Zulauf,José Van der Heyden,Geert Plaetinck,(unknown),Jan Tavernier,Walter Fiers,(unknown),A. D’Arcy	8
17	Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells. 1990 ·The Journal of Experimental Medicine ·Geert Plaetinck,José Van der Heyden,Jan Tavernier,(unknown),T Tuypens,Steven Fischkoff,Walter Fiers,René Devos	76
18	Expression of Human and Murine Interleukin-5 in Eukaryotic Systems 1989 ·DNA ·Jan Tavernier,René Devos,José Van der Heyden,(unknown),(unknown),(unknown),Eric Kawashima,Joël Vandekerckhove,Roland Contreras,Walter Fiers	45
19	Treatment of Murine Interferon-α/β-Sensitive and -Resistant Friend Leukemia Cells with Tumor Necrosis Factor in Combination with Murine Interferon-α/β or -γ 1986 ·Journal of Interferon Research ·José Van der Heyden,Lucie Fransen,Walter Fiers	4
20	Purification of Recombinant Glycosylated Human Gamma Interferon Expressed in Transformed Chinese Hamster Ovary Cells 1984 ·Journal of Interferon Research ·René Devos,(unknown),(unknown),José Van der Heyden,Walter Fiers	28

About José Van der Heyden

José Van der Heyden is a scholar working on Immunology, Endocrine and Autonomic Systems and Virology, having authored 61 papers that have together received 4.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (19 papers), Cytokine Signaling Pathways and Interactions (13 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). The work is most often cited by research in Immunology (2.1k citations), Endocrine and Autonomic Systems (395 citations) and Immunology and Allergy (283 citations). José Van der Heyden has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Jan Tavernier, René Devos, Walter Fiers, Geert Plaetinck, Lucie Fransen, Walter Fiers, Sigrid Cornelis, T Tuypens, Yves Guisez and Annick Verhee. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact